The call is open for researchers with research activities linked to one of the departments at Campus Flemingsberg.
The researcher Emma Andersson receives Swedish Foundation's Starting Grant 2019 for research within developmental biology.
A common and inexpensive drug may be used to counteract treatment resistance in patients with acute myeloid leukemia (AML), one of the most common forms of blood cancer. This is the conclusion of a study in mice and human blood cells performed at Karolinska Institutet and SciLifeLab and published in the medical journal EMBO Molecular Medicine. The researchers will now launch a clinical study to test the new combination treatment in patients.
The transcription factor DAF-16/FOXO mediates a wide variety of aging-preventive responses by driving the expression of stress-resistance and longevity promoting genes. Ilke Sen and other members of the Riedel lab could show that transcriptional initiation at many DAF-16/FOXO target genes depends on dephosphorylation of SPT-5 by Protein Phosphatase 4.
KI researcher Emma Andersson receives Swedish Foundations' Starting Grant 2019 for research in developmental biology.
In a new study published in Circulation Research, researchers at Karolinska Institutet show that the enzyme PCSK6, the proprotein convert subtilisin / kexin 6, plays a key role in vascular disease. The findings give hope that PCSK6 may become a future target molecule for the development of anti-vascular disease drugs.
The NU conference is Sweden's largest meeting place for the development of higher education. It will take place 7-9 October 2020 at several higher education institutions at Campus Flemingsberg, including Karolinska Institute. You as an employee at KI have the opportunity to get the conference fee paid.
The bicycle garage in Biomedicum needs to be tidied up and in order to do so we will need to empty it entirely.
15 Jan 2020Current calls, week 3, 2020
Tips from Grants Office about current calls
The Unit for Teaching and Learning (TL) are now looking for a course leader for the Introductory Doctoral Supervision Course.
In a new study published in Nature Communications, researchers at Karolinska Institutet show that MAIT cells (mucosa-associated invariant T cells), part of the human immune system, respond with dynamic activity and reprogramming of gene expression during the initial phase of HIV infection. The study fills a knowledge gap, as previously there has been a lack of awareness of the function of MAIT cells during this particular phase.
Two new research programmes focusing on AI and bioelectronic medicine, for application in the areas of breast cancer and inflammatory disease, respectively, have been adopted at MedTechLabs. An interdisciplinary centre run by KTH, Karolinska Institutet and the Stockholm Region.
Places are advertised within the clinical research schools in family medicine and primary care, epidemiology and molecular medicine.
A letter from 17 group leaders at BioNut was in December sent to KI President with a wish to explore the possibilities for the whole Department to move to Biomedicum. KI President stated that experimental research must be present at both campuses of KI.
New opportunities to get liquid nitrogen safety training for Biomedicum staff will be offered on 5 February and on 3 March 2020, starting at 09:00.
The post-doctoral programme for leading research, Pro Futura Scientia, provides promising young European researchers financing for independent research. The 15 participants of the 2019-2020 programme have also been offered a leadership programme, Leadership in Academia, given by Karolinska Institutet in collaboration with Riksbankens Jubileumsfond (the Swedish Foundation for Humanities and Social Sciences).
On Friday January 31, Yunzhang Wang will defend his thesis "DNA methylation and aging : a longitudinal study of old Swedish twins".
Congratulations Pawel Kozielewicz! You are the Highlighted Trainee Author for the January 2020 Issue of Molecular Pharmacology.
On 13-15 December, researchers from the three departments GPH, MTC and MBB at Karolinska Institutet, participated in the Joint Programming Initiative on Antimicrobial Resistance Hackathon: Using the digital world to fight antimicrobial resistance. A three-day event that seeks to produce innovative digital products or prototypes that can bring concrete solutions to address the issue of Antimicrobial Resistance.
10 Jan 2020Long-term medication for schizophrenia is safe
Researchers at Karolinska Institutet and their colleagues in Germany, the USA and Finland have studied the safety of very long-term antipsychotic therapy for schizophrenia. According to the study, which is published in the scientific journal World Psychiatry, mortality was higher during periods when patients were not on medication than when they were.
Patients with the inflammatory bowel disease ulcerative colitis have a higher risk of dying from colorectal cancer, despite modern therapy, even though the risk has declined in recent years. This is according to a new study published in the scientific journal The Lancet by a team of Swedish and Danish researchers.
A recent paper published in Science Advances by scientists at Karolinska Institutet in a large joint effort with Hungarian, Japanese, Swedish and American researchers demonstrates a previously unknown mechanism by which cells can protect proteins from irreparable damage by oxygen. Because this damage occurs in diseases such as cardiovascular, neurodegenerative conditions and cancer, the mechanism helps us to better understand these diseases.
Meeting at IMM with WHO Network for Chemical Risk Assessment working group for Community of Trainers.
Open rehersal 20 january 2020. No previous choir experience is required.
Researchers at Karolinska Institutet have developed a method based on artificial intelligence for histopathological diagnosis and grading of prostate cancer. The AI-system has the potential to solve one of the bottlenecks in today’s prostate cancer histopathology by providing more accurate diagnosis and better treatment decisions. The study, presented in The Lancet Oncology, shows that the AI-system is as good at identifying and grading prostate cancer as world-leading uro-pathologists.
Professor Sten Eirik Waelgaard Jacobsen, Karolinska Institutet and University of Oxford, was elected member of the Academy's Class for medical sciences on November 27, 2019.
Annika Hanberg, IMM, Programme director for the ToxMaster programme, was awarded ”Mäster 2019” by the Student Union at KI Medicinska Föreningen at their Lucia ball on the 13 December 2019.
7 Jan 2020Senior Professor Arne Holmgren has died
Arne Holmgren, Senior Professor at Karolinska Institutet, died on January 6, 2020, 79 years old. Dr. Holmgren was widely known as one of the groundbreaking scientists establishing the rapidly growing field of redox biology.
Using a trick involving detergent and mass spectrometry, a research group has been able to wash and weigh protein molecules to determine which lipids make the protein work. The findings may help design molecules that stick to individual membrane proteins and pave the way for the development of new drugs including antibiotics and cancer therapies. The study is published in Angewandte Chemie International Edition.
3 Jan 2020New software licensing prices from 2020
From 2020, new prices for software licenses will apply as a result of updates and adjustments in the agreements with Karolinska Institutet's licensing partners.
3 Jan 2020Nominate recipients of KI's medals 2020-2021
From the jubilee year of 2010 and onwards, Karolinska Institutet awards medals to people who have made special efforts in support of KI's activities. There are three categories: the Gold Medal, the Large Silver Medal and the Silver Medal. Medals are awarded in conjunction with various academic ceremonies.
Researchers at Karolinska Institutet have come one step closer toward understanding how the part of our brain that is central for decision-making and the development of addiction is organized on a molecular level. In mouse models and with methods used for mapping cell types and brain tissue, the researchers were able to visualize the organization of different opioid-islands in striatum. Their spatiomolecular map, now in Cell Reports, may further our understanding of the brain’s reward-system.
Researchers at Karolinska Institutet have deciphered the diabetogenic role of a certain type of calcium channel in insulin-secreting beta cells. The researchers believe that blockade of these channels could be a potential new treatment strategy for diabetes. The study is published in the scientific journal PNAS.
Christina H. Opava summarized her career at KI in an entertaining talk prior to her retirement, led by Yvonne Enman, journalist and honorary doctor at KI.
Systembolagets Alkoholforskningsråd has awarded projects grants to four research projects at the Department of Global Public Health.
20 Dec 2019Detailed map of immune cells in human blood
Researchers at SciLifeLab report in the journal Science that they have created a detailed blood atlas of the proteins in human immune cells. The open-access database offers medical researchers an unprecedented resource in the search for treatments for diseases.
Glutamine could help people with obesity reduce inflammation of fat tissue and reduce fat mass, according to a new study at Karolinska Institutet in Sweden and the University of Oxford in the U.K. The researchers also show how glutamine levels can alter gene expression in several different cell types. However, more research is needed before glutamine supplementation may be recommended as a treatment for obesity. The study is published in the journal Cell Metabolism.
19 Dec 2019Meeting on Alzheimer Research
During one of few sunny days in November, about 290 Alzheimer researchers and other interested people from all over Sweden gathered in Aula Medica. It was Center for Alzheimer Research that had invited to the Swedish Meeting for Alzheimer research on 20 November.
Researchers at Karolinska Institutet, together with colleagues from the EU-funded project HUMAN, recently published a study on a new animal model for studies of human lipoprotein metabolism and pharmacodynamics. The study is a result of the EU project HUMAN using a new animal model and new technologies to study aging and cardiometabolic diseases.
19 Dec 2019Research grants to Susanna Brighenti
Congratulations to Associate professor Susanna Brighenti at CIM who receives research grants for her group´s studies on new concepts for host-directed therapy in tuberculosis.
She receives the grant for ”New diagnostic tools and treatment for Alzheimer's disease, traumatic brain injury and small vascular disease” and it is distributed over three years.
Cognitive Behavioural Therapy (CBT) for patients with social anxiety not only helps to reduce anxiety levels but also seems to protect against accelerated cellular ageing, a study involving researchers at Karolinska Institutet published in the journal Translational Psychiatry reports.
The search for a cure to AIDS has partly focused on ways to eradicate infected cells. Now, new research from Karolinska Institutet in Sweden and the University of Pennsylvania in the U.S. shows that this approach may not be necessary for a functional cure. In a study focusing on a subset of HIV-positive individuals who can live with the virus without needing treatment, the researchers found that these people’s lymphocytes suppress the virus but do not kill off infected cells.
High blood levels of the lipid lipoprotein(a) in people with type 1 diabetes add to the already elevated risk of developing cardiovascular disease, researchers from Karolinska Institutet report in a paper published in the prestigious journal Diabetes Care. Lipoprotein(a) levels should therefore be measured in patients with type 1 diabetes and form part of the total risk assessment, say the researchers.
Two KI researchers receive research project grant for international collaboration within rare diseases (EJP Rare diseases) from the Swedish Research Council.
Two researchers at Karolinska Institutet are awarded the Strategic Mobility Grant from the Swedish Foundation for Strategic Research (SSF). The aim of the SSF mobility programme is to increase exchange between Swedish universities and industry by funding researchers’ work with a project managed by the other part.
Jakob Wikström at KI is one of this year’s three Wallenberg Clinical Fellows. The purpose of the program is to encourage clinical research by Swedish physicians. The funding is for three years and is provided by the Marianne and Marcus Wallenberg Foundation.
This year's silver medals are awarded to senior professors Lena von Koch and Björn Klinge. The medal is awarded to a person who has made excellent efforts to support the activities of Karolinska Institutet. The medals are awarded in conjunction with the ceremony for Diligence and Devotion.